Life Sciences Partners, a European life sciences investor, held the final closing of its latest fund at €112m (approximately $155m).
LPs include Dutch, German and French health insurance companies, family offices and asset managers.
Led by René Kuijten, general partner, and Rudy Dekeyser, managing partner, Health Economics Fund (LSP HEF) invests in healthcare companies commercializing products in the areas of medical technology, diagnostics and eHealth. It focuses on products or technologies of high relevance to patients, care providers and, given the global rise in healthcare costs, to society at large.
The fund backs in Europe and North America, focusing on later stage private companies with products on the market or close to market introduction.
Its first investment was IlluminOss Medical, a US company commercializing a minimally invasive approach to orthopedic implants for the treatment of bone fractures.
LSP has offices in Amsterdam, Munich and Boston.
FinSMEs
14/03/2014